AMH Equity’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-110,000
Closed -$703K 54
2025
Q1
$703K Buy
+110,000
New +$1.06M 1.06% 30
2024
Q4
Sell
-20,000
Closed -$554K 59
2024
Q3
$554K Buy
+20,000
New +$500K 0.7% 36
2023
Q4
Sell
-362,970
Closed -$3.14M 36
2023
Q3
$3.14M Sell
362,970
-637,030
-64% -$4.53M 3.45% 12
2023
Q2
$7.89M Buy
+1,000,000
New +$6.96M 9.02% 4
2022
Q3
Sell
-100,000
Closed -$1.21M 23
2022
Q2
$988K Sell
100,000
-221,414
-69% -$4.47M 1.7% 17
2022
Q1
$11.1M Buy
321,414
+178,714
+125% +$5.8M 11.49% 2
2021
Q4
$7.11M Buy
+142,700
New +$7.52M 9.88% 3

Other funds holding ASPN

AMH Equity's ASPN Position: Q2 2025 in Review

AMH Equity sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 110,000 shares — an estimated $703K sold.

AMH Equity first reported a position in ASPN in Q4 2021 and held it in 7 quarters. The position peaked at $11.1M in Q1 2022. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • AMH Equity reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • AMH Equity sold 110,000 Aspen Aerogels shares in Q2 2025, an estimated $703K.
  • AMH Equity first reported a position in Aspen Aerogels in Q4 2021 and held it in 7 quarters.
  • AMH Equity's Aspen Aerogels position peaked at $11.1M in Q1 2022.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on AMH Equity's 13F filing for Q2 2025, filed 4 Aug 2025.